Combined impact of the inter and intra-patient variability of tacrolimus blood level on allograft outcomes in kidney transplantation
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.1037566
Abstract: Introduction Tacrolimus (TAC) has been widely used as an immunosuppressant after kidney transplantation (KT); however, the combined effects of intra-patient variability (IPV) and inter-patient variability of TAC-trough level (C0) in blood remain controversial. This study… read more here.
Keywords: allograft outcomes; high ipv; inter; ipv ... See more keywords